Recently, removal of circulating soluble and PD-L1-positive extracellular vesicles from periphery through plasmapheresis (i.e., a manipulation of the internal climate) has been developed as a therapeutic intervention in melanoma, as an adjunctive of immunotherapy (90). This evidence concerns the gene CD274 and melanoma.